References
- ASTDR. Toxicological profile for lead. Atlanta: Agency for toxic substances and disease registry; 2007.
- EFSA panel on contaminants in the food chain (CONTAM). scientific opinion on lead in food. EFSA Journal. 2010;8:1570.
- NTP. Monograph on health effects of low-level lead evaluation. U.S.: Department of Health and Human Services, National toxicology program; 2012.
- WHO. WHO model lists of essential medicines. Geneva: World Health Organization; 2017.
- Bradberry S, Vale A. Dimercaptosuccinic acid (succimer; DMSA) in inorganic lead poisoning. Clin Toxicol. 2009;47:617–631.
- Graziano JH, Lolacono NJ, Meyer P. Dose-response study of oral 2,3-dimercaptosuccinic acid in children with elevated blood lead concentrations. J Pediatr. 1988;113:751–757.
- Graziano JH, Lolacono NJ, Moulton T, et al. Controlled study of meso-2,3-dimercaptosuccinic acid for the management of childhood lead intoxication. J Pediatr. 1992;120:133–139.
- Wang SC, Ting KS, Wu CC. Chelating therapy with Na-DMS in occupational lead and mercury intoxications. Chin Med J. 1965;84:437–439.
- Friedheim E, Graziano JH, Popovac D, et al. Treatment of lead poisoning by 2,3-dimercaptosuccinic acid. Lancet. 1978;2:1234–1236.
- Lee BK, Schwartz BS, Stewart W, et al. Provocative chelation with DMSA and EDTA: evidence for differential access to lead storage sites. Occup Environ Med. 1995;52:13–19.
- Garnier R, Fournier E, L’épreuve de plomburie provoquée par l’EDTANa2Ca: validation d’un test court (5 heures) [The leadurie test provoked by the EDTANa2Ca: validation of a short test (5 hours)]. Paris: Université Paris Diderot; 1986. French.
- Liang YY, Marlowe C, Waddell WJ. Disposition of [14C]dimercaptosuccinic acid in mice. Fundam Appl Toxicol. 1986;6:532–540.
- Bradberry S, Vale A. A comparison of sodium calcium edetate (edetate calcium disodium) and succimer (DMSA) in the treatment of inorganic lead poisoning. Clin Toxicol. 2009;47:841–858.
- Fournier L, Thomas G, Garnier R, et al. 2,3-dimercaptosuccinic acid treatment of heavy metal poisoning in humans. Med Toxicol Adverse Drug Exp. 1988;3:499–504.
- Fischer Walker CL, Black RE. Functional indicators for assessing zinc deficiency. Food Nutr Bull. 2007;28:S454–S479.
- Hess SY, Peerson JM, King JC, et al. Use of serum zinc concentration as an indicator of population zinc status. Food Nutr Bull. 2007;28:S403–S429.
- Graziano JH, Siris ES, LoIacono N, et al. 2,3-dimercaptosuccinic acid as an antidote for lead intoxication. Clin Pharmacol Ther. 1985;37:431–438.
- Bradberry S, Sheehan T, Vale A. Use of oral dimercaptosuccinic acid (succimer) in adult patients with inorganic lead poisoning. QJM. 2009;102:721–732.
- Mann KV, Travers JD. Succimer, an oral lead chelator. Clin Pharm. 1991;10:914–922.
- Liebelt EL, Shannon M, Graef JW. Efficacy of oral meso-2,3-dimercaptosuccinic acid therapy for low-level childhood plumbism. J Pediatr. 1994;124:313–317.
- Chisolm JJ Jr. Safety and efficacy of meso-2,3-dimercaptosuccinic acid (DMSA) in children with elevated blood lead concentrations. J Toxicol Clin Toxicol. 2000;38:365–375.
- Group TT. Safety and efficacy of succimer in toddlers with blood lead levels of 20–44 microg/dL. Treatment of lead-exposed children (TLC) trial group. Pediatr Res. 2000;48:593–599.
- Farrar HC, McLeane LR, Wallace M, et al. A comparison of two dosing regimens of succimer in children with chronic lead poisoning. J Clin Pharmacol. 1999;39:180–183.
- O'Connor ME, Rich D. Children with moderately elevated lead levels: is chelation with DMSA helpful? Clin Pediatr. 1999;38:325–331.
- Volans GN, Karalliedde L, Wiseman HM. Review of Succimer for Treatment of Lead Poisoning. Geneva: World Health Organization; 2010.
- Vogt W, Cottier H. [Necrotizing nephrosis after treatment of a subacute- chronic lead poisoning with high dosed versenate]. Schweiz Med Wochenschr. 1957;87:665–667. German.
- Wedeen RP, Batuman V, Landy E. The safety of the EDTA lead-mobilization test. Environ Res. 1983;30:58–62.
- Moel DI, Kumar K. Reversible nephrotoxic reactions to a combined 2,3-dimercapto-1-propanol and calcium disodium ethylenediaminetetraacetic acid regimen in asymptomatic children with elevated blood lead levels. Pediatrics. 1982;70:259–262.
- Yver L, Marechaud R, Picaud D, et al. [Acute renal failure in the course of occupational lead intoxication. Chelation therapy responsability (author's transl)]. Nouv Presse Med. 1978;7:1541–1543. French.
- Araki S, Aono H, Murata K. Mobilisation of heavy metals into the urine by CaEDTA: relation to erythrocyte and plasma concentrations and exposure indicators. Br J Ind Med. 1986;43:636–641.